CVE-2011-2082

Description

The vulnerable-passwords script in Best Practical Solutions RT 3.x before 3.8.12 and 4.x before 4.0.6 does not update the password-hash algorithm for disabled user accounts, which makes it easier for context-dependent attackers to determine cleartext passwords, and possibly use these passwords after accounts are re-enabled, via a brute-force attack on the database. NOTE: this vulnerability exists because of an incomplete fix for CVE-2011-0009.

Category

5.0
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 0.37%
Third-Party Advisory secunia.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://lists.bestpractical.com/pipermail/rt-announce/2012-May/000203.html patch mailing list
http://secunia.com/advisories/49259 third party advisory
http://lists.bestpractical.com/pipermail/rt-announce/2012-May/000204.html patch mailing list
http://lists.bestpractical.com/pipermail/rt-announce/2012-May/000202.html mailing list
http://www.securityfocus.com/bid/53660 vdb entry

Frequently Asked Questions

What is the severity of CVE-2011-2082?
CVE-2011-2082 has been scored as a medium severity vulnerability.
How to fix CVE-2011-2082?
To fix CVE-2011-2082, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2011-2082 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2011-2082 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.